{"id":"W2085214163","doi":"10.1016/s0960-9776(09)70271-1","title":"Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer","year":2009,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Bevacizumab; Sunitinib; Oncology; Sorafenib; Internal medicine; Breast cancer; Drug; Antiangiogenic therapy; Metastatic breast cancer; Cancer; Taxane; Chemotherapy; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002765158,0.0003726538,0.0007638964,0.00003021428,0.0001687679,0.00002172991,0.0005927515,0.0001753747,0.00002871688],"category_scores_gemma":[0.000006127822,0.00013751,0.002134242,0.0001430698,0.0001743039,0.000002582606,0.00006273555,0.00005319761,0.000001238809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008066197,"about_ca_system_score_gemma":0.0003414412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00142626,"about_ca_topic_score_gemma":0.00003299056,"domain_scores_codex":[0.998776,0.0001043459,0.0004025628,0.0002973049,0.0001299493,0.0002898718],"domain_scores_gemma":[0.9983547,0.00008916688,0.0005335525,0.0008567828,0.0001310352,0.00003471409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008340435,0.00006579915,0.00002871244,0.0004077455,0.001500797,1.728079e-7,0.00008881267,0.00002533908,0.0007206306,0.0000135249,0.001409247,0.9956558],"study_design_scores_gemma":[0.0007478201,0.0007507858,0.001018219,0.002201206,0.005154879,0.0003786482,0.0001896785,0.00005358203,0.001778026,0.00001880879,0.9871576,0.0005507168],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008508678,0.996318,0.00004428874,0.0001823469,0.0001089846,0.0009621299,0.001478412,0.000004608243,0.00005035202],"genre_scores_gemma":[0.01373032,0.9841591,0.00001508871,0.00001654283,0.001186566,0.0002048462,0.00007732914,0.00005027777,0.000559925],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9951051,"threshold_uncertainty_score":0.5607495,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0270583760729518,"score_gpt":0.3530794942608489,"score_spread":0.3260211181878971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}